Applications

1678 – Integrating Pharmacists within Aboriginal Community Controlled Health Services to Improve Chronic Disease Management (IPAC Project)

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation Not applicable
  • Pre-MSAC consultation Closed
  • Outcome Supported

Application details

Reason for application

The Sixth Community Pharmacy Agreement provided funding to support a Pharmacy Trial Program (PTP), which seeks to improve clinical outcomes for patients and/or utilise the full scope of a pharmacist’s role in delivering primary health care services.

The outcomes of all PTP Trials will undergo an independent health technology assessment to determine the effectiveness and cost-effectiveness of the trial intervention and inform decisions about any broader rollout. A decision to fund any future programs would be a matter for Government.

Information on the PTP is available on the Department of Health’s website.

Service or technology in this application

The IPAC Project assessed the outcomes associated with integrating pharmacists providing medication management services into Aboriginal Community Controlled Health Services (ACCHSs) compared with usual care (pre-intervention).

Type: Therapeutic technology

Medical condition this application addresses

The IPAC trial recruited regular clients of ACCHSs who had a diagnosis of:

  • Cardiovascular disease (coronary heart disease, stroke, hypertension, dyslipidaemia and any other cardiovascular disease),
  • Type 2 diabetes mellitus,
  • Chronic kidney disease, or
  • Other chronic conditions and at high risk of developing medication-related problems (e.g. polypharmacy).

Application documents

IPAC public summary

Consultation survey

Public summary document – March/April 2022

Final stakeholder meeting minutes

Public summary document – March 2023

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Consultation survey and deadlines

  • PASC consultation: Not applicable
  • MSAC consultation: Closed 11 February 2022

Meetings to consider this application

  • PASC meeting: Bypassing PASC
  • ESC meeting: 10 to 11 February 2022
  • MSAC meeting: 31 March to 1 April 2022 and 30 to 31 March 2023
  • Stakeholder meeting: Monday 10 October 2022
    Members of MSAC, representatives of the applicant from the Pharmaceutical Society of Australia, National Aboriginal Community Controlled Health Organisation (NACCHO) and James Cook University; representatives from Aboriginal Health Services (AHS) and Aboriginal Community Controlled Health Services (ACCHS); representatives from the Northern Territory Health Service; and representatives from the Department of Health and Aged Care met to discuss Integrating Pharmacists within Aboriginal Community Controlled Health Services to Improve Chronic Disease Management (IPAC Project). This was not an MSAC decision forum, but a meeting to seek stakeholder input on issues raised by MSAC during its March-April 2022 consideration of Application 1678 – IPAC Project. The final minutes of this meeting are above.